Turatti M - Search Results

1

Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.

Gajofatto A, Bongianni M, Zanusso G, Bianchi MR, Turatti M, Benedetti MD, Monaco S. Gajofatto A, et al. Among authors: turatti m. Acta Neurol Scand. 2013 Nov;128(5):336-44. doi: 10.1111/ane.12123. Epub 2013 Apr 1. Acta Neurol Scand. 2013. PMID: 23550839

2

Benign multiple sclerosis: physical and cognitive impairment follow distinct evolutions.

Gajofatto A, Turatti M, Bianchi MR, Forlivesi S, Gobbin F, Azzarà A, Monaco S, Benedetti MD. Gajofatto A, et al. Among authors: turatti m. Acta Neurol Scand. 2016 Mar;133(3):183-91. doi: 10.1111/ane.12442. Epub 2015 May 26. Acta Neurol Scand. 2016. PMID: 26009804

3

A case of acute fulminant multiple sclerosis treated with alemtuzumab.

Gobbin F, Marangi A, Orlandi R, Richelli S, Turatti M, Calabrese M, Forgione A, Alessandrini F, Benedetti MD, Monaco S, Gajofatto A. Gobbin F, et al. Among authors: turatti m. Mult Scler Relat Disord. 2017 Oct;17:9-11. doi: 10.1016/j.msard.2017.06.007. Epub 2017 Jun 20. Mult Scler Relat Disord. 2017. PMID: 29055482

4

Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.

Zanoni M, Orlandi E, Rossetti G, Turatti M, Calabrese M, Gomez Lira M, Gajofatto A. Zanoni M, et al. Among authors: turatti m. Acta Neurol Scand. 2020 Nov;142(5):511-516. doi: 10.1111/ane.13288. Epub 2020 Jun 5. Acta Neurol Scand. 2020. PMID: 32432792

5

Assessment of outcome predictors in first-episode acute myelitis: a retrospective study of 53 cases.

Gajofatto A, Monaco S, Fiorini M, Zanusso G, Vedovello M, Rossi F, Turatti M, Benedetti MD. Gajofatto A, et al. Among authors: turatti m. Arch Neurol. 2010 Jun;67(6):724-30. doi: 10.1001/archneurol.2010.107. Arch Neurol. 2010. PMID: 20558391

6

Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.

Turatti M, Gajofatto A, Bianchi MR, Ferrari S, Monaco S, Benedetti MD. Turatti M, et al. J Neurol Sci. 2013 Jan 15;324(1-2):156-62. doi: 10.1016/j.jns.2012.10.026. Epub 2012 Nov 11. J Neurol Sci. 2013. PMID: 23151425

7

Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study.

Gajofatto A, Stefani A, Turatti M, Bianchi MR, Lira MG, Moretto G, Salviati A, Benedetti MD. Gajofatto A, et al. Among authors: turatti m. Eur J Neurol. 2013 Apr;20(4):697-703. doi: 10.1111/ene.12045. Epub 2012 Dec 24. Eur J Neurol. 2013. PMID: 23279712

8

Siponimod to treat secondary progressive multiple sclerosis.

Gajofatto A, Turatti M. Gajofatto A, et al. Among authors: turatti m. Drugs Today (Barc). 2020 Jan;56(1):37-46. doi: 10.1358/dot.2020.56.1.3091905. Drugs Today (Barc). 2020. PMID: 32055804 Review.

9

Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.

Gajofatto A, Turatti M, Monaco S, Benedetti MD. Gajofatto A, et al. Among authors: turatti m. Drug Healthc Patient Saf. 2015 Dec 11;7:157-67. doi: 10.2147/DHPS.S69640. eCollection 2015. Drug Healthc Patient Saf. 2015. PMID: 26715860 Free PMC article. Review.

10

Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives.

Gajofatto A, Turatti M, Benedetti MD. Gajofatto A, et al. Among authors: turatti m. Expert Rev Neurother. 2017 Apr;17(4):393-406. doi: 10.1080/14737175.2017.1257385. Epub 2016 Nov 15. Expert Rev Neurother. 2017. PMID: 27813441 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters